Oral, thyroid stimulating hormone receptor (TSHR) antagonist improved thyroxine (T4) hormone levels and histological parameters associated with Graves’ disease in a preclinical model SOUTH SAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results